In vitro activities of Eravacycline against 336 isolates collected from 2012 to 2016 from 11 teaching hospitals in China

BACKGROUND: In China multidrug-resistant bacteria pose a considerable threat to public health. Antimicrobial resistance has weakened the effectiveness of many medicines widely used today. Thus, discovering new antibacterial drugs is paramount in the effort to treat emerging drug-resistant bacteria....

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Chunjiang, Wang, Xiaojuan, Zhang, Yawei, Wang, Ruobing, Wang, Qi, Li, Henan, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558774/
https://www.ncbi.nlm.nih.gov/pubmed/31182038
http://dx.doi.org/10.1186/s12879-019-4093-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558774/
https://www.ncbi.nlm.nih.gov/pubmed/31182038
http://dx.doi.org/10.1186/s12879-019-4093-1

Ejemplares similares